NDA Review ‘Program’ On Track, But Is It Still Doomed?
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
PDUFA V granted FDA an additional two months to complete application reviews, but agency data indicates median review time, influenced by priority review speed, only increased by one month in FY 2013.